Helen Macpherson (AU)

Subscribe to all posts by Helen Macpherson (AU)

Fakes welcome? IP protection lags behind for Indigenous artworks in Australia

In a symbolic win for Indigenous artists, the Federal Court of Australia has recently ordered a seller of fake Indigenous-style souvenirs to pay AU$2.3 million in pecuniary penalties for contraventions of the misleading and deceptive conduct provisions of the Australian Consumer Law (ACL). While the Court’s ruling appears to be a positive move in the … Continue reading

Calidad v Seiko – defining the scope of the implied licence

One of the more controversial questions in patent law is the extent to which a patentee may continue to exercise control over patent-protected goods after their sale. This question invokes competing tensions between the rights of the patentee and the rights of the purchaser to free enjoyment of goods they have purchased. In a number … Continue reading

Don’t Rokt the boat: developments in the patentability of computer implemented inventions in Australia

With the continued rise of digital technologies and mining of big data, computer implemented inventions (CIIs) are being increasingly utilised in a wide range of industries. CIIs enable companies to deliver more personalised products and solutions to consumers, whether in the form of more personalised medical treatments and diagnostic tools in the pharmaceutical and healthcare … Continue reading

V Energy loses a mother of a battle over color trademark: Australia court’s decision in Frucor v Coca-Cola

We, as consumers, regularly associate colours with our favourite brands as we stroll down supermarket aisles and peer at billboards and banners in shopping centres.  But for brand holders, gaining protection for proprietary colours is not a walk in the (green) park.  The recent decision of Frucor Beverages Limited v The Coca-Cola Company [2018] FCA … Continue reading

Australia – No extensions for Swiss style Pharma Patents

A Full Court of the Federal Court has confirmed that patents containing “Swiss-style” claims are outside the scope of the Australian patent term extension regime in its recent judgment of Commissioner of Patents v AbbVie Biotechnology Ltd [2017] FCAFC 129. What it means: Patents which claim methods or processes involving pharmaceutical substances cannot be extended … Continue reading

Court decision highlights difficulty in challenging innovation patents

Late last month, Justice Burley handed down his decision in Doric Products Pty Ltd v Asia Pacific Trading (Aust) Pty Ltd [2017] FCA 849. The decision provides a useful illustration of how Australian Courts will approach construction, infringement and validity issues in innovation patent proceedings, and emphasises the difficulties respondents face when challenging the validity … Continue reading
LexBlog